Actively Recruiting

Age: 14Years +
All Genders
NCT06152627

Voice Therapy Per the Rehabilitation Treatment Specification System

Led by Massachusetts General Hospital · Updated on 2026-02-18

600

Participants Needed

5

Research Sites

73 weeks

Total Duration

On this page

Sponsors

M

Massachusetts General Hospital

Lead Sponsor

E

Emory University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this study is to evaluate if using evidence-based, standard ingredient and target codes from the Rehabilitation Treatment Specification System - Voice Therapy (RTSS-Voice) in standard of care voice therapy documentation can improve outcomes for patients with muscle tension dysphonia (MTD). The main question it aims to answer is: Since the RTSS-Voice will help clinicians think about their treatment more specifically and in relation to nine evidence-based therapies, will its adoption be associated with improved outcomes? Clinicians across five voice centers will be asked to use the RTSS-Voice to document their voice therapy sessions for patients with MTD. Researchers will compare changes in outcomes between two groups of patients: those treated during the clinician's first year using the RTSS-Voice versus those treated during the clinician's second year using the RTSS-Voice.

CONDITIONS

Official Title

Voice Therapy Per the Rehabilitation Treatment Specification System

Who Can Participate

Age: 14Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of primary Muscle Tension Dysphonia (pMTD)
  • Includes all subtypes of pMTD such as functional aphonia, vocal fry, and ventricular dysphonia
  • Patients may have secondary diagnoses of reflux
  • Age 14 years or older
Not Eligible

You will not qualify if you...

  • Secondary diagnoses related to structural, neurological, or respiratory disorders such as laryngitis, vocal fold nodules, polyps, cysts, granuloma, sulci, paradoxical vocal fold motion, chronic cough, upper airway paralysis or paresis, dysphagia, polypoid corditis, keratosis, presbylarynx, leukoplakia, or history of head/neck radiation
  • Non-English speakers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Emory University

Atlanta, Georgia, United States, 30322

Actively Recruiting

2

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

3

New York University

New York, New York, United States, 10017

Actively Recruiting

4

University of Utah

Salt Lake City, Utah, United States, 84132

Actively Recruiting

5

University of Wisconsin

Madison, Wisconsin, United States, 53792

Actively Recruiting

Loading map...

Research Team

J

Jarrad Van Stan, PhD, CCC-SLP

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here